TP53 and ovarian carcinoma: Within the panel of ovarian cancer cell lines studied, wild-type TP53 cell lines were significantly more sensitive to Nutlin-3 and the more potent RG7388 compared to mutant TP53 cell lines, which is consistent with their mechanism of action [28].